ArticleJournal of the ASEAN Federation of Endocrine Societies2026

Dapagliflozin Alone or Combined With Semaglutide: Cardiovascular and Renal Outcomes Among Patients With Type 2 Diabetes Mellitus in a 6-Month Real-World Retrospective Cohort Study in Saudi Arabia.

Rasmah Alharajin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.